2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
43
Liver Neoplasms
14
Colorectal Neoplasms
10
Recurrence
6
Cholangiocarcinoma
6
Neoplasm Metastasis
5
Pancreatic Neoplasms
3
Colonic Neoplasms
3
Rupture, Spontaneous
2
Postoperative Complications
2
Tissue Adhesions
1
Stomach Neoplasms
1
Secondary Malignant Neoplasm of Liver
1
Sarcopenia
1
Reperfusion Injury
1
Obesity, Morbid
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Metabolic Syndrome
1
Long-term Effects of Cancer Treatment
1
Liver Surgery
1
Liver Failure
1
Klatskin Tumor
1
Ischemia
1
Hypertension, Portal
1
Hemangioma
1
Focal Nodular Hyperplasia
1
Fibrosis
1
Disseminated Pancreatic Cancer
1
Disease Progression
1
Interventions
Metformin
7
Testosterone
2
Pioglitazone
2
Magnetic Resonance Spectroscopy
2
Inositol
2
Exercise
2
Ethinyl Estradiol
2
Blood Pressure
2
semaglutide
1
maltodextrin
1
drospirenone and ethinyl estradiol combination
1
drospirenone
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Walking
1
Vascular Stiffness
1
Ultrasonography
1
Triptorelin Pamoate
1
Topiramate
1
Tirzepatide
1
Sugars
1
Spironolactone
1
Qsymia
1
Pyruvic Acid
1
Pulse Wave Analysis
1
Preoperative Exercise
1
Phlebotomy
1
Phentermine
1
Pancreaticoduodenectomy
1
Orchiectomy
1
Observation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Metabolic Syndrome
×
Hepatectomy
×
Clear all
NCT06060847
2023-12-19
LIRESS
Ospedale V. Fazzi
Phase NA
Not yet recruiting
50 enrolled